In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.
In Nature this week: novel soil-dwelling bacteria may be source of molecules with biomedical potential, and more.
Three CRISPR researchers are to receive the Kavli Prize in nanoscience, according to the Associated Press.
Inder Verma had been on leave from PNAS since December after three female scientists at the Salk Institute filed a lawsuit claiming gender discrimination.
Reuters reports that the panel hearing the CRISPR gene editing patent case appears split.
The company said it plans to develop a CRISPR-enabled platform capable of detecting any biomarker or disease containing DNA or RNA.
Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.
Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.
Genome editing will likely first touch many people's lives through its use in agriculture, says the University of California, Berkeley's Jennifer Doudna at the Financial Times.
In Science this week: CRISPR-based approach for recording cellular events, and more.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.